Managing hypoglycemia in outpatient practice

Hypoglycemia is a state in which blood glucose drops below 3.9 mmol/L (per ADA 2023). It's not "low sugar", it's an acute condition that requires immediate action. Here is the outpatient playbook: what to do in the first 60 seconds, how to avoid rebound hyperglycemia, when CGM is indicated, and the mistakes colleagues commonly make.

Definition and grading

Per the international classification (ISPAD 2022, ADA 2023):

| Level | Blood glucose | Clinical picture | |---------|--------------|---------| | Level 1 (alert) | < 3.9 mmol/L | Tremor, sweating, tachycardia | | Level 2 (clinically significant) | < 3.0 mmol/L | Cognitive impairment, confusion | | Level 3 (severe) | assistance required | Loss of consciousness, seizures |

Protocol when conscious (levels 1–2)

The 15-15 rule:

1. 15 g of fast-acting carbohydrate: 3–4 dextrose tablets, 150 mL of juice, 1 tablespoon of honey, 3 sugar cubes. Not chocolate — fat slows absorption.
2. Wait 15 minutes, repeat the glucometer reading.
3. If glucose is still < 3.9 — repeat 15 g of carbohydrate.
4. Once stabilised — 15 g of slow carbohydrate (bread, biscuits) to prolong recovery.

Don't give sweet tea — a large fluid volume during nausea provokes vomiting. Don't give insulin "for correction" — that's the worst advice we see.

Protocol on loss of consciousness (level 3)

In hospital or with a stocked kit:

• 40% glucose, 20–60 mL IV bolus (or 10% glucose 200–400 mL by drip)
• Check glucose every 5 minutes until it reaches 5–6 mmol/L
• Once stabilised — maintenance 5% glucose drip

In outpatient settings without a kit:

• Glucagon 1 mg intramuscular (thigh, shoulder) — relatives should be trained
• Place the patient on their side (aspiration risk on regaining consciousness)
• Call emergency services — glucagon buys time until they arrive, but doesn't replace full care

Causes — what to look for

Once the patient is stable, work through the etiology:

Silent nocturnal hypoglycemia. The most common and the most dangerous. Almost impossible to detect without CGM: the patient doesn't wake on early symptoms, sleeps through until 04:00, has "normal" morning glucose (post-hypoglycemic rebound). Suspect it if the patient reports morning headaches, sweating on the sheets, nightmares. Confirm only with 1–2 weeks of continuous monitoring.

Missed meal + basal insulin. Common in working patients on intensive insulin therapy. The fix is to adjust the basal dose, not to skip insulin.

Drug interactions. Beta-blockers mask symptoms. Alcohol blocks gluconeogenesis. Salicylates and warfarin potentiate sulfonylureas. Check the full medication list.

Post-exercise hypoglycemia. Physical activity raises insulin sensitivity for 24+ hours. The patient may have trained in the evening and crashed at 03:00.

Sulfonylureas in the elderly. Glibenclamide in patients 70+ with CKD is a slow-fuse landmine. Hypoglycemia can last 24–48 hours and requires hospitalisation.

When CGM is indicated

Continuous glucose monitoring is clinically justified when:

• The patient has frequent or unexplained hypoglycemia
• There is suspicion of nocturnal hypoglycemia (even one episode in the history)
• Hypoglycemia unawareness — the patient has lost the early autonomic warning signs (often after repeated episodes, especially in long-standing T1D)
• Pregnancy with diabetes — the target range 3.5–7.8 mmol/L requires 70%+ TIR
• Children and adolescents on intensive insulin therapy
• Patients with renal impairment on sulfonylureas

CGM in these cases isn't "convenience", it's a clinical-safety tool.

Common colleague mistakes (from practice)

1. "Give sweet tea and insulin for correction" — produces rebound hyperglycemia and often a fresh hypoglycemia an hour later.
2. Ignoring hypoglycemia unawareness — the patient needs 2 weeks of restored sensitivity through temporarily relaxed targets.
3. Glucose overdose — 100 g of carbohydrate instead of 15. A sharp jump to 18–20 mmol/L then needs insulin — a vicious cycle.
4. Not investigating the cause — settling the episode and discharging the patient without CGM follow-up. A week later they're back in the office.

Discharge checklist

Before sending the patient home after an episode:

• [ ] Glucose stably > 5.5 mmol/L on two readings 30 minutes apart
• [ ] Patient fully alert, oriented
• [ ] Accompanied by someone
• [ ] Glucometer + CGM sensor prescribed for the next 2 weeks
• [ ] Follow-up scheduled in 14 days with data ready
• [ ] Family trained in the 15-15 rule and glucagon use

References

• ADA Standards of Medical Care in Diabetes — 2023. Diabetes Care 2023;46(Suppl. 1).
• ISPAD Clinical Practice Consensus Guidelines 2022.
• Battelino T. et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation. Diabetes Care. 2019;42(8):1593-1603.